secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001493152-24-036888
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical closes IPO of 1.5M shares at $3.00, net proceeds ~$3.76M
--------------------------------------------------------------------------

- IPO of 1,500,000 common shares at $3.00 per share; net proceeds to company ~$3,764,500 after discounts and expenses.
- Shares began trading on NYSE American on Sept 16, 2024 under ticker IBO; offering closed Sept 17, 2024.
- Underwriters granted 45-day option to buy up to 225,000 additional shares at IPO price less discount.
- Representative's warrants issued for 75,000 shares (5% of offering) at $3.75/share, exercisable from 9 months to 3 years.
- Company and insiders subject to 6-month lock-up on share sales after effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224036888/0001493152-24-036888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224036888/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer